Fidelity Select Biotechnology Portfolio FBIOX

Medalist Rating as of | See Fidelity Investment Hub
  • NAV / 1-Day Return 28.68  /  +1.52 %
  • Total Assets 5.9B
  • Adj. Expense Ratio
    0.620%
  • Expense Ratio 0.620%
  • Distribution Fee Level Low
  • Share Class Type No Load
  • Category Health
  • Investment Style Mid Blend
  • Min. Initial Investment 0
  • Status Open
  • TTM Yield 1.46%
  • Turnover 45%

USD | NAV as of Jul 18, 2026 | 1-Day Return as of Jul 18, 2026, 4:47 AM GMT+0

Morningstar’s Analysis FBIOX

Will FBIOX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Fidelity Select Biotechnology holds a quantitatively derived Silver Morningstar Medalist Rating. The rating reflects that it has scored well on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FBIOX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 45.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Krystal Biotech Inc

10.58 557M
Healthcare

AbbVie Inc

9.22 486M
Healthcare

Amgen Inc

6.53 344M
Healthcare

Gilead Sciences Inc

4.82 254M
Healthcare

Alnylam Pharmaceuticals Inc

2.93 155M
Healthcare

Praxis Precision Medicines Inc Ordinary Shares

2.47 130M
Healthcare

Insmed Inc

2.25 119M
Healthcare

argenx SE ADR

2.25 118M
Healthcare

Ascendis Pharma AS

2.04 108M
Healthcare

Revolution Medicines Inc Ordinary Shares

2.02 106M
Healthcare

Sponsor Center